Koers High Hampton Holdings Corp Canadian Securities Exchange
Aandelen
CA42966X2005
Farmaceutische producten
Omzet 2022 | - | Omzet 2023 | - | Marktkapitalisatie | 563K 414K 381K |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | - 0 0 | Nettowinst (verlies) 2023 | - 0 0 | EV/omzet 2022 | - |
Nettoliquiditeiten 2022 | 841K 618K 569K | Nettoliquiditeiten 2023 | 690K 507K 467K | EV/omzet 2023 | - |
K/w-verhouding 2022 |
22,9
x | K/w-verhouding 2023 |
-8,18
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 95,16% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Robert Dubeau
CEO | Chief Executive Officer | - | 26-09-23 |
Director of Finance/CFO | 53 | 19-09-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director of Finance/CFO | 53 | 19-09-23 | |
Robert Dubeau
CEO | Chief Executive Officer | - | 26-09-23 |
Anderson Shannon
BRD | Director/Board Member | - | 19-09-23 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+32,09% | 693 mld. | |
+29,39% | 584 mld. | |
-1,34% | 372 mld. | |
+20,34% | 332 mld. | |
+7,39% | 294 mld. | |
+14,25% | 239 mld. | |
-3,03% | 211 mld. | |
+10,02% | 210 mld. | |
+8,49% | 168 mld. |